Substance Use Disorders (SUD)Safety & Risk ManagementImplementation & Service DeliveryPublic Health, Prevention & Behaviour Change

Toward a positive psychology of psychoactive drug use

This paper (2021) makes a case for broadening our conceptualization of substance use in order to develop more effective drug policy and education. It is argued that we need to move beyond our current framing of substance use as a pathological issue and that research on recreational drug use would be beneficial. Incorporating perspectives on positive drug use would enhance prevention and harm reduction strategies.

Authors

  • Arnaud, K. O. S.

Published

Drugs Education Prevention and Policy
meta Study

Abstract

This article advances the proposition that contemporary perspectives on psychoactive drug use are epistemologically limited and that a broadened conceptualization of substance use would aid the development of more effective drug policy and education. It contends that psychoactive substance use cannot be accounted for from an exclusively pathological frame of reference and that by neglecting positive drug instrumentalization, opportunities to advance public health, safety, and well-being are being overlooked. Using the field of positive psychology as a point of comparison, this article thus argues for greater acknowledgment of, and research on, beneficial recreational substance use. The adaptive function of psychoactive drug use and the limitations of conceptual discourse which fails to distinguish between deleterious and salubrious use are first discussed. This is followed by an overview of the cartography of psychoactive drug use and consideration of biopsychosocial parameters germane to positive drug instrumentalization. The classic psychedelics are highlighted due to their psychopharmacological properties and tendency to evoke self-transcendent states. Limitations of regulatory and educational approaches grounded exclusively in the pathological paradigm are broached, with a discussion of how incorporating perspectives on positive drug use would complement extant models of prevention and harm reduction. Areas for future research are considered.

Available with Blossom Pro

Research Summary of 'Toward a positive psychology of psychoactive drug use'

Introduction

Over recent decades, scholarship and public policy have emphasised the harms of psychoactive substances—substance use disorders, substance-induced disorders, and associated physical, psychological, and social consequences. St and colleagues argue that this dominant medico-legal and clinical discourse has become epistemologically narrow by largely treating drug use as inherently pathological. The introduction frames this imbalance as analogous to the historical focus of clinical psychology on psychopathology, which prompted the rise of positive psychology to study wellness and flourishing alongside disorder. This paper sets out to broaden the conceptual landscape of substance use by foregrounding the positive end of the drug-use spectrum. Rather than denying the reality of addiction and harm, St proposes that complementary research on beneficial, controlled, or instrumental drug use could improve drug policy, education, prevention, and public health. The article therefore offers a theoretical comparison with positive psychology, discusses adaptive and evolutionary accounts of psychoactive use, outlines a spectrum of outcomes, examines biopsychosocial parameters that predict beneficial versus harmful use, highlights classic psychedelics as particularly relevant, and considers implications for regulation, education, and future research.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (28)

Papers cited by this study that are also in Blossom

Classic hallucinogens in the treatment of addictions

Bogenschutz, M. P., Johnson, M. W. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016)

The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens

Canal, C. E., Murnane, K. S. · Journal of Psychopharmacology (2016)

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

Carhart-Harris, R. L., Nutt, D. J. · Journal of Substance Use (2010)

The paradoxical psychological effects of lysergic acid diethylamide (LSD)

Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)

253 cited
Peak Experiences of Psilocybin Users and Non-Users

Cummins, C., Lyke, J. · Journal of Psychoactive Drugs (2013)

17 cited
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)

A Public-Health-Based Vision for the Management and Regulation of Psychedelics

Haden, M., Emerson, B., Tupper, K. W. · Journal of Psychoactive Drugs (2016)

28 cited
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

Halberstadt, A. L. · Behavioural Brain Research (2014)

Constructing drug effects: a history of set and setting

Hartogsohn, I. · Drug Science Policy and Law (2017)

389 cited
Show all 28 references
143 cited
Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Hendricks, P. S., Clark, B., Johnson, M. W. et al. · Journal of Psychopharmacology (2014)

89 cited
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)

345 cited
Potential Therapeutic Effects of Psilocybin

Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)

Human hallucinogen research: guidelines for safety

Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)

Drugs as instruments: A new framework for non-addictive psychoactive drug use

Schumann, G., Müller, C. P. · Behavioral and Brain Sciences (2011)

A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience

Neitzke-Spruill, L., Glasser, C. · Journal of Psychoactive Drugs (2018)

Psychedelics

Nichols, D. E. · Pharmacological Reviews (2016)

Psychedelics and the science of self-experience

Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)

Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI)

Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)

Effects of Schedule I drug laws on neuroscience research and treatment innovation

King, C., Nichols, D. E. · Nature Reviews Neuroscience (2013)

The pharmacology of lysergic acid diethylamide: a review

Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)

The pharmacology of psilocybin

Passie, T., Seifert, J., Schneider, U. et al. · Addiction Biology (2002)

Adverse Reactions to Psychedelic Drugs - A Review of the Literature

Strassman, R. J. · Journal of Nervous and Mental Disease (1984)

273 cited
Psilocybin - Summary of knowledge and new perspectives

Tylš, F., Páleníček, T., Horacek, J. · European Neuropsychopharmacology (2013)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.